BioSpace News Archive

Gravity Diagnostics, a CAP-accredited and CLIA certified laboratory licensed in all 50 states, has announced the hire of Brian Lawrence, Ph.D. as Chief Technology Officer and General Manager of B2B and consumer products.

As clinical applications for whole slide imaging and digital pathology rapidly advance, the College of American Pathologists, in collaboration with the American Society for Clinical Pathology and the Association for Pathology Informatics, has updated the guideline “Validating Whole Slide Imaging for Diagnostic Purposes in Pathology,” published as an early online release in Archives of Pathology & Laboratory Medicine.

Micro-Tech Endoscopy recently launched the largest clip in its Lockado line of Hemostasis Clips with a 22mm jaw opening.

The Utah PTA recently passed an important resolution to bring migraine and headache education into the classroom statewide, while also providing much needed resources for students, parents, administrators, educators, and nurses.

Study uses mobile device technology to support capture of patient-reported outcomes during early and ongoing use of study treatment amongst patients with rheumatoid arthritis

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, reported the grant of non-qualified stock options to purchase an aggregate of 4,677 shares of common stock of the company and 7,100 restricted stock units of the company’s common stock to a newly hired non-executive officer of the company.

Sientra, Inc., a medical aesthetics company uniquely focused on plastic surgeons, announced that members of management are scheduled to participate in two upcoming virtual investor conferences.

Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, announced today that, due to the continuing public health concerns relating to the coronavirus (COVID-19) pandemic, and to protect the health and well-being of its shareholders, employees, and other stakeholders, Opiant’s 2021 Annual Meeting of Shareholders will be held in a virtual-only meeting

Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult to treat oncology indications, announced today that it was awarded a Small Business Innovative Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID)

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced an oral presentation of preclinical data from the company’s ALPN-303 program at the European Alliance of Associations for Rheumatology (EULAR) European Congress of Rheumatology Virtual Meeting to be held June 2-5, 2021.